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Summary 
 
The objective: to evaluate the processes of pathomorphosis and relationship 
between factors of apoptosis and functional state of dendritic cells in the 
endometrium of the women with endometrial hyperplasia. Materials and 
Methods. The treatment group consisted of 50 women, 25 - with simple 
hyperplasia (group I) and 25 - with atypical glandular-cystic hyperplasia (group II)  
of endometrium. Control set included 20 healthy women of the same age. The 
expression of activation markers CD16 +, CD56 +, CD1a, CD85k and CD123 on the 
surface of lymphocytes was studied by flow cytometry. Determination of CD 
receptors in endometrial biopsies performed by immunohistochemical method with 
the use of  monoclonal antibodies LIR, Dardilly (France) to CD56 +, CD83 +, CD1a+. 
Identification of tissue antigens was performed by avidin-biotin method. 
Expression of the antiapoptosis protein BCL-2 protein and proapoptosis protein 
CVC was observed in the cytoplasm of cells, it differed in intensity of staining. 
Statistical analysis of the results is made by methods of variance and correlation 
analysis using software Statistica 10.0.  Results. In immunohistochemical study of 
endometrial biopsies of the women with atypical and simple  hyperplasia it was 
established that dendritic cells CD56 + and CD83 + showed a high level of 
expression. Differences with control are reliable in group II (p <0.05). At the same 
time it was found that the degree of expression of factors Bcl-2 and BAX was 
either weak or moderate (1-2 +;  less frequently 3 +) in the women with atypical 
endometrial hyperplasia and negative - in healthy women and women with simple 
endometrial hyperplasia. The level of expression of markers of apoptosis in the 
second group correlated (r = 0.54) with the severity of the expression of dendritic 
cells. This demonstrates the important role of the functional state of dendritic cells 
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in the regulation of cell proliferation and apoptosis activity in the women with 
endometrial hyperplasia. The results obtained demonstrate the feasibility of the use  
in the diagnostic algorithm in patients with endometrial hyperplasia estimation of 
the functional state of dendritic cells.  
Key words: dendritic cell, marker of apoptosis, hyperplasia of endometrium.  
 
РЕФЕРАТ 
 
Запорожан В. Н., Фетеску С. А., Маричереда В. Г. АНАЛИЗ 
ФУНКЦИОНАЛЬНОГО СОСТОЯНИЯ ДЕНДРИТНЫХ КЛЕТОК CD56+, 
CD83+, CD1A + И МАРКЕРОВ АППОТОЗА BCL2, ВАХ ПРИ 
ГИПЕРПЛАСТИЧЕСКИХ ПРОЦЕССАХ ЭНДОМЕТРИЯ (Одесский 
национальный медицинский университет, Украина).  
Целью исследования была оценка процессов патоморфоза и 
взаимосвязь между факторами апоптоза и функциональным состоянием 
дендритных клеток в эндометрии женщин, страдающих гиперпластическими 
процессами эндометрия. Материалы и методы. Основную группу составили 
50 женщин, 25 - с простой гиперплазией (I группа) и 25 - с атипической 
железисто-кистозной гиперплазией (II группа) эндометрия. В качестве 
контроля обследованы 20 практически здоровых женщин того же возраста. 
Экспрессию активационных маркеров CD16 +, CD56 +, CD1a, CD85k и CD123 на 
поверхности лимфоцитов изучали методом проточной цитофлуориметрии. 
Определение содержания CD рецепторов в биоптатах эндометрия проведено 
иммуногистохимическим методом с использованием моноклональных 
антител LIR, Dardilly (Франция) к CD56 +, CD83+, CD1a+. Выявление тканевых 
антигенов проводили авидин-биотиновим методом. Экспрессия 
антиапоптозного белка BCL2 и проапоптозного белка ВАХ исследовали в 
цитоплазме клеток, отличалась по интенсивности окрашивания. 
Статистическая обработка полученных результате проведена методами 
дисперсионного и корреляционного анализа с использованием программного 
обеспечения Statistica 10.0. Результаты. При иммуногистохимическом 
исследовании биоптатов эндометрия женщин с простой и атипической 
гиперплазией, установлено, что дендритные клетки CD56+ и CD83+ 
демонстрировали высокий уровень экспрессии. Различия с контролем были 
достоверными во II группе (р <0,05). Вместе с тем установлено, что степень 
экспрессии факторов Bcl-2 и ВАХ была слабой или умеренной (1-2 +, реже 3 
+) у женщин с атипическойой гиперплазией эндометрия и отрицательной - у 
здоровых женщин и женщин с простой гиперплазией эндометрия. При этом 
уровень экспрессии маркеров апоптоза во II группе коррелировал (r = 0,54) с 
выраженностью экспрессии дендритных клеток. Это свидетельствует о 
существенной роли функционального состояния дендритных клеток в 
регуляции клеточной пролиферации и активности апоптоза у женщин с 
гиперпластическими процессами эндометрия. Приведенное свидетельствует 
о целесообразности применения в диагностическом алгоритме у пациенток с 
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гиперпластическими процессами эндометрия оценки функционального 
состояния антиген дендритных клеток. 
 Ключевые слова: дендритная клетка, маркер апоптоза, гиперплазия 
эндометрия 
 
 
 
 
 
Background of endometrial hyperplastic processes (EHP) is defined  by wide 
prevalence of this disease, its tendency to long - term recurrent course, against 
which if untreated, may occur malignant lesions of the mucous membrane of the 
uterus. Unflagging interest to the problem of EHP is determined not only by the  
need to comply cancer suspicion, but the frequent detection of persistent 
recurrences,  involving women of reproductive age menstrual irregularities, 
development of anemia, reproductive dysfunctions [1-5].  
The basis of cyclic alterations of the endometrium  are  very peculiar molecular 
mechanisms of morphological and functional changes of the endometrium in 
different phases of the normal menstrual cycle [3]. It is known that an important 
intracellular process in the endometrium is apoptosis, which maintains cellular 
homeostasis during the menstrual cycle by eliminating ageing cells from the 
functional layer of the endometrium of the uterus [6-8].  At that disturbance of 
apoptosis and related pathological changes of cells is the base of the hyperplastic 
and neoplastic diseases of the endometrium [8]. There is scientific evidence that 
depending on the functional state of dendritic cells in patients with endometrial 
hyperplastic processes, apoptosis intensity changes [9]. 
But finally the relationship between factors of apoptosis and functional state of 
dendritic cells is still not understood.  
In this context, the objective of the study was to evaluate the processes and 
pathomorphosis relationship between factors of apoptosis and functional state of 
dendritic cells in the endometrium of women suffering from endometrial 
hyperplasia.  
Material and Methods.  The research  has been conducted at the clinical sites of 
the Department of Obstetrics and Gynecology №1 of  Odessa National Medical 
University and on the base of Odessa Regional Clinical  Hospital in 2010-2011. 50 
women with endometrial hyperplasia ( 25 patients with simple and  25 with 
atypical glandular-cystic hyperplasia)  have been comprehensively examined 
according to existing clinical protocols regulated by the orders of Ukrainian 
Ministry of Health Care [9, 10]. The average age of the patients was 33,6 ± 0,8 
years. Control set included 20 healthy women of the same age.  
The expression of activation markers CD16 +, CD56 +, CD1a, CD85k and CD123 on the 
surface of lymphocytes was studied by flow cytometry. The device «FACScan»  
(Becton Dickinson)  and direct dial monoclonal antibodies and isotypic controls of 
the same company were used.  
Determination of CD receptors in endometrial biopsies was  performed through 
immunohistochemical method using monoclonal antibodies LIR, Dardilly (France) 
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to CD56 +, CD83 +, CD1a +. The material for the study was obtained by biopsy of  
uterine mucosa of the patients under examination 2-3 days before the predicted 
time of menstruation. The Paypel curette or fractional medical diagnostic 
excochleation of the uterus mucous membrane and cervical canal.  
Scrapings from the uterus with intact endometrium in different phases of the 
menstrual cycle and histological sections of patients with endometrial hyperplasia 
have been investigated  immunohistochemically. The tissue sections  (4-5 mc 
thick) were fixed in neutral formalin and embedded in paraffin. The slices of tissue 
were placed on the glass coated with  poly-E-lysine, or treated with a solution of 
ovalbumin by 3-4 samples. The sections were stained with hematoxylin and eosin, 
by MSB (orange, red, blue) to detect disruption of connective tissue, van Gieson’s 
picrofuchsin mixture technique to identify the degree of sclerosis, periodic Acid 
Schiff reaction to detect neutral and acidic mucopolysaccharides.  
Identification of tissue antigens was performed by avidin-biotin technique where 
biotin-modified secondary antibodies reacted  with the appropriate molecules of 
peroxidase-conjugated streptavidin. The method is highly sensitive and allows  to 
visualize the location of antigens. When setting immunohistochemical reaction the  
universal DAKO LSAB + kit (Dako corporation, USA) was used. Expression of 
the antiapoptosis protein Bcl-2  and proapoptosis protein  BAX was observed in 
the cellular cytoplasm and differed in intensity of  staining. Evaluation of research 
results expressed in points: 0 - no reaction, 1 - weak reaction, 2 - moderate 
reaction, 3 - strong reaction.  
Statistical analysis of the results is made by methods of variance and correlation 
analysis using software Statistica 10.0 [10].  
Results. 
The course of the disease in the patients with THP was stereotypic. 
Menometrorrhagiae  were observed in 20 (80.0%) women from the  1
st
 and in 21 
women (84.0%) from the 2
nd
 group. Hyperpolymenorrhea and algomenorrhea was  
observed respectively in 32.0% and 36.0% of the first and second group patients. e 
6 (24.0%) women of the 1
st
 group and 4 (16.0%)women of the 2
nd
 group  
mentioned about long-term (over 5 years)  wearing of untrauterine device. More 
than three abortions were recorded in 9 (36.0%) patients with simple glandular 
hyperplasia of the endometrium and 10 (40.0%) with atypical hyperplasia. 
Hereditary tained cancer  history  had 12 (48.0%) patients of the 1
st
  group, and 11 
(44.0%) in the second group and in 3 (15.0%) patients in the control group.  There 
were no statistically significant differences between the first and second groups 
patients (p> 0,05).  
In the study of lymphocyte subpopulations it has been revealed that the most 
characteristic phenomena of immunological changes was the increased content of 
natural killer cells (CD16 + , CD56 +) to 13.2 ± 0.6% in the patients of the 2nd group 
and to 11.3 ± 0.8% in the patients of the 1st group, as in the control set this index  
did not exceed 9.4 ± 0.4% (p <0,05). In addition, for the patients with endometrial 
hyperplasia changing of  the ratio of T suppressor and cytotoxic cells ( 0.8 ± 0.05% 
in the first group and 0.9 ± 0.08%  in the second group and 1.3 ± 0.1% in the 
control set ) was characteristic (p <0,05). However, the depletion of population  
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CD1 and growth of CD85 and CD123 was observed, respectively to 0.6 ± 0.03% and 
up to 9.20 ± 0.9% and 4.4 ± 0.5%  in the first group and 0.7 ± 0.05% and up to 
9.12 ± 0.8% and 4.3 ± 0.4%  in the second group. In the control set the number of 
CD1a + cells was 1.2 ± 0.05% (p <0,05), CD85 – 7.1 ± 0.4%, CD123 – 3.9 ± 0.4% (p> 
0.05).  
In healthy women in the early stage of proliferation phase ( the 5
th
 -7
th
 day of the 
menstrual cycle) endometrium is thin with scattered, narrow and straight glands, 
which are evenly placed in a free stroma consisting of spindle-shaped cells. The 
glands have the form of straight or slightly convoluted tubules with narrow 
opening. On cross-section the contours of glands are rounded or oval. The 
epithelium of the glands is monostichous, low, prismatic-shaped with small, 
rounded or oval intensely colored with condensed chromatin nuclei, located at the 
base of the cell. Cytoplasm is basophilic and homogeneous. Apical edge of 
epithelial cells is  even and clearly delineated. 
Histological structure of the unchanged endometrium  was as follows in the 
secondary stage endometrial proliferation (8-10 day). The glands are straight and 
slightly convoluted, due to their elongation,  epithelial cells are high and prismatic 
in shape. The nuclei of epithelial cells are located at different levels (in places), 
and are  slightly enlarged or more increased in comparison with the early stages of 
proliferation, oval in form, they are less intensely stained and some of them have 
small nucleoli, mitosis is often observed.  
In the late stage phase of proliferation (11-14 day) chalazae have a pronounced 
tortuosity at their staining with hematoxylin and eosin than in the middle stage, and 
their lumen is slightly expanded. The epithelium of the glands is  tall, prismatic, 
apical edge of the cell are level, clear. As a result of intensive segmentation and 
increase of  epithelial cells number, their nuclei are at different levels. Thus, the 
epithelium overlaying the glands is pseudopolynucleated by the location of  nuclei 
at different levels. The nuclei increase in size and become oval, contain small well 
visualized nucleoli,  mitosis are common. Cytoplasm of epithelial cells becomes 
poor. At the late phase of proliferation in epithelial cells of some glands there are 
subnuclear vacuoles.  
Compared with previous descriptions  the endometrial glands were more 
convoluted at the early stage of secretion (15-18 day) and their  lumen was dilated. 
In the epithelium of the thyroid subnuclear  vacuoles.  The nuclei were pushed by 
the vacuoles in the central parts of the cells. The shape of nuclei was rounded.   
Cytoplasm of the cells was basophilic. Mitosis were rare.  
The main characteristics of unchanged endometrium in the middle stage of 
secretion  phase (19-23 day) were as follows. The epithelium of the glands in the 
middle stage of  secretion was monostichous, and the most of the nuclei were  
located in the basal part of the epithelial cells. All the nuclei were round, light 
bubble. The apical part of  epithelial cells became domed. The lumens of the 
glands dilated, their walls became folded. The epithelium of the glands was 
monostichous,  with the nuclei located basally. As a result of intensive secretion 
the cells were low, their apical edge was not clearly expressed, as if they had 
serrations. There was secret in the lumen of the glands. In the late stage of 
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secretion (24-28 day) the folding of the glands walls was increased, they had 
pronounced stellate shape in cross-section and dustlike - in the longitudinal 
section. The nuclei of some epithelial cells had sights of  pycnosis.  
In contrast with atypical endometrial hyperplasia the following changes  were 
observed in the phase of proliferation. Glandular component significantly prevailed 
over stromal. The glands were held tightly to each other, and  separated by  narrow 
layers of connective tissue, convoluted, with numerous arborizations, their shape 
irregular, wavy, scalloped due to papillary outgrowths that went into the lumen of 
the glands. The cells lining the glands, were large, mainly due to increase in the 
cytoplasm, which may be basophilic, bright translucent and sometimes got 
eosinophilic staining. The nuclei of the cells were either large oval or elongated, 
with distinct clumps of chromatin and large nucleoli,  painted pale. Polarity  of 
nuclei location was broken.  
At simple hyperplasia the  predominance of glandular component, without 
disturbing of the polarity of nuclei location in the phase of proliferation. It was no 
noticeable close location of the glands. The glands were  rounded and varied in 
size. Along with  small sized glands,  large and cysts-like dilated glands were 
found in different ratios. The glands were lined with  highly prismatic      
epithelium  with multi located nuclei and well-rounded apical cell edge. The nuclei 
were oval or slightly elongated, cigar-shaped, rich in chromatin. The cytoplasm 
was basophilic, the secret was usually absent in it, although in the ducts of the 
glands a small amount of mucicarmine stained mucus might be found. In glandular 
and stromal cells figures of mitosis were often met. It  indicates active proliferation 
of both glandular and stromal elements.  
At immunohistochemical study of endometrial biopsies of women with  simple and 
atypical hyperplasia (Table ), it had been revealed that dendritic cells CD56 (+) and 
CD83 (+) demonstrated  high  expression. Differences with control were reliable in 
group II (p <0.05). 
Table 
Expression of markers antigenpresenting cells in patients with endometrial 
hyperplasia 
indicators simple 
hyperplasia 
atypical 
hyperplasia 
control 
CD1a+ 1.3 ± 0.2 2.2 ± 0.2 0.9 ± 0.1 
CD56+ 1.5 ± 0.2 1.9 ± 0.2 1.3 ± 0.1 
CD83+ 1.6 ± 0.1 2.1 ± 0.2 1.2 ± 0.1 
Note: * - differences from control are significant (p <0.05)  
At the same time it has been revealed that the degree of expression of Bcl-2 and 
BAX factors was either  weak or moderate (1-2 +,  at least 3 +) in women with 
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atypical endometrial hyperplasia and negative  in healthy women and women with 
simple endometrial hyperplasia (Fig. 1) . 
 
Figure 1. Expression of apoptosis markers in the second group of women (A - Bcl-2, B - BAX). 
Rev. 10, approx. 20 
 The level of expression of apoptosis markers  in the second group correlated (r = 
0.54) with the severity of the expression of dendritic cells. This demonstrates the 
important role of the functional state of dendritic cells in the regulation of cell 
proliferation and apoptosis activity in women with endometrial hyperplasia. In 
other words, the activation of apoptosis provides a "recycling" of atypical 
endometrial cells. 
Conclusions: 
1. Pathomorphosis at atypical endometrial hyperplasia is characterized by increase 
correlation between stromal and glandular component with  predominance of 
glandular one, increased expression of markers of dendritic cells and apoptosis. 
2. Dendritic cells in the  patients with atypical endometrial hyperplasia 
demonstrated significantly higher expression level compared with healthy women 
and patients with simple endometrial hyperplasia. 
3. The level of expression of markers of apoptosis in patients with atypical 
endometrial hyperplasia correlated (r = 0.54) with the severity of the expression of 
dendritic cells.  
4. The results obtained demonstrate the feasibility of  use in the diagnostic 
algorithm in patients with endometrial hyperplasia assessment of the functional 
state of antigenpresenting dendritic cells. 
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